Induction of efflux-mediated macrolide resistance in Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 7, 2011, Pages 3413-3422

  Chancey, Scott T ^a,b   Zhou, Xiaoliu ^a,b,c   Zähner, Dorothea ^a,b   Stephens, David S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMINOSUGAR; AZITHROMYCIN; BACITRACIN; CLARITHROMYCIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; DIRITHROMYCIN; DISACCHARIDE; ERYTHROMYCIN; JOSAMYCIN; KITASAMYCIN; LEVOFLOXACIN; LINCOMYCIN; MACROLIDE; MEF(E) PROTEIN; MIDECAMYCIN; MONOSACCHARIDE; MULTIDRUG RESISTANCE PROTEIN; OLEANDOMYCIN; PEPTIDYLTRANSFERASE; POLYMYXIN B; ROXITHROMYCIN; SPIRAMYCIN; TELITHROMYCIN; TILMICOSIN; TROLEANDOMYCIN; TULATHROMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISK DIFFUSION; DRUG DETERMINATION; DRUG RESPONSE; ENZYME ACTIVITY; GENE INDUCTION; GENETIC TRANSCRIPTION; NONHUMAN; OPERON; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIBOSOME; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MACROLIDES; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE;

EID: 79959264022     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00060-11     Document Type: Article

References (51)

1. Alloing, G., C. Granadel, D. A. Morrison, and J.-P. Claverys. 1996. Competence pheromone, oligopeptide permease, and induction of competence in Streptococcus pneumoniae. Mol. Microbiol. 21:471-478.
2. Alloing, G., B. Martin, C. Granadel, and J.-P. Claverys. 1998. Development of competence in Streptococcus pneumoniae: pheromone autoinduction and control of quorum sensing by the oligopeptide permease. Mol. Microbiol. 29:75-83.
3. Ambrose, K. D., R. Nisbet, and D. S. Stephens. 2005. Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible. Antimicrob. Agents Chemother. 49:4203-4209.
4. Bailey, M., T. Chettiath, and A. S. Mankin. 2008. Induction of erm(C) expression by noninducing antibiotics. Antimicrob. Agents Chemother. 52:866-874.
5. Bejuk, D. 2004. Differentiation of resistance phenotypes among erythromycin-resistant streptococci. Acta Med. Croatica 58:301-306. (Pubitemid 40137525)
6. Berisio, R., et al. 2003. Structural insight into the antibiotic action of telithromycin against resistant mutants. J. Bacteriol. 185:4276-4279. (Pubitemid 36835269)
7. Berisio, R., et al. 2003. Structural insight into the role of the ribosomal tunnel in cellular regulation. Nat. Struct. Biol. 10:366.
8. Bonnefoy, A., A. Girard, C. Agouridas, and J. Chantot. 1997. Ketolides lack inducibility properties of MLS(B) resistance phenotype. J. Antimicrob. Chemother. 40:85-90.
9. Braga, P. C. 2002. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides. J. Chemother. 14:115-131. (Pubitemid 34454625)
10. Clancy, J., et al. 1996. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22:867-879.
11. CLSI. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI document M100-S20. CLSI, Wayne, PA.
12. Daly, M. M., S. Doktor, R. Flamm, and D. Shortridge. 2004. Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates. J. Clin. Microbiol. 42:3570-3574.
13. Dinos, G. P., S. R. Connell, K. H. Nierhaus, and D. L. Kalpaxis. 2003. Erythromycin, roxithromycin, and clarithromycin: use of slow-binding kinetics to compare their in vitro interaction with a bacterial ribosomal complex active in peptide bond formation. Mol. Pharmacol. 63:617-623.
14. Farrell, D. J., et al. 2005. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg. Infect. Dis. 11:851-858.
15. Gay, K., et al. 2000. The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. J. Infect. Dis. 182:1417-1424.
16. Gay, K., and D. S. Stephens. 2001. Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. J. Infect. Dis. 184:56-65.
17. Giovanetti, E., M. P. Montanari, F. Marchetti, and P. E. Varaldo. 2000. In vitro activity of ketolides telithromycin and HMR 3004 against Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. J. Antimicrob. Chemother. 46:905-908.
18. Halfmann, A., R. Hakenbeck, and R. Bruckner. 2007. A new integrative reporter plasmid for Streptococcus pneumoniae. FEMS Microbiol. Lett. 268:217-224.
19. Hansen, J. L., et al. 2002. The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol. Cell 10:117-128. (Pubitemid 34876566)
20. Havarstein, L. S., G. Coomaraswamy, and D. A. Morrison. 1995. An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. Proc. Natl. Acad. Sci. U. S. A. 92:11140-11144.
21. Hui, F. M., and D. A. Morrison. 1991. Genetic transformation in Streptococcus pneumoniae: nucleotide sequence analysis shows comA, a gene required for competence induction, to be a member of the bacterial ATP-dependent transport protein family. J. Bacteriol. 173:372-381.
22. Jenkins, S., and D. Farrell. 2009. Increase in pneumococcus macrolide resistance, United States. Emerg. Infect. Dis. 15:1260-1264. http://www.cdc.gov/EID/content/15/8/1260.htm.
23. Johnston, N. J., J. C. de Azavedo, J. D. Kellner, and D. E. Low. 1998. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2425-2426.
24. Kamimiya, S., and B. Weisblum. 1997. Induction of ermSV by 16-membered-ring macrolide antibiotics. Antimicrob. Agents Chemother. 41:530-534.
25. Klugman, K., and J. Lonks. 2005. Hidden epidemic of macrolide-resistant pneumococci. Emerg. Infect. Dis. 11:802-807.
26. Klugman, K. P. 2002. Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections. Eur. Respir. J. 20:3S-8S.
27. Korshunova, G., et al. 2007. Peptide derivatives of tylosin-related macrolides. Russ. J. Bioorg. Chem. 33:218-226.
28. Kwak, J. H., E. C. Choi, and B. Weisblum. 1991. Transcriptional attenuation control of ermK, a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus licheniformis. J. Bacteriol. 173:4725-4735.
29. Kwon, A. R., et al. 2006. ErmK leader peptide: amino acid sequence critical for induction by erythromycin. Arch. Pharm. Res. 29:1154-1157.
30. Lampson, B. C., W. von David, and J. T. Parisi. 1986. Novel mechanism for plasmid-mediated erythromycin resistance by pNE24 from Staphylococcus epidermidis. Antimicrob. Agents Chemother. 30:653-658.
31. Martin, B., M. Prudhomme, G. Alloing, C. Granadel, and J.-P. Claverys. 2000. Cross-regulation of competence pheromone production and export in the early control of transformation in Streptococcus pneumoniae. Mol. Microbiol. 38:867-878.
32. Mayford, M., and B. Weisblum. 1989. ermC leader peptide. Amino acid sequence critical for induction by translational attenuation. J. Mol. Biol. 206:69-79.
33. Mayford, M., and B. Weisblum. 1990. The ermC leader peptide: amino acid alterations leading to differential efficiency of induction by macrolide-lincosamide-streptogramin B antibiotics. J. Bacteriol. 172:3772-3779. (Pubitemid 20213355)
34. Mazzariol, A., R. Koncan, L. A. Vitali, and G. Cornaglia. 2007. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae. J. Antimicrob. Chemother. 59:1171-1176.
35. Miller, J. H. 1972. Experiments in molecular genetics. A laboratory manual and handbook for Escherichia coli and related bacteria. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
36. Nishijima, T., et al. 1999. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics. J. Antimicrob. Chemother. 43:637-643.
37. Pfister, P., et al. 2004. The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23S rRNA positions 2058 and 2059. J. Mol. Biol. 342:1569-1581.
38. Poulsen, S. M., C. Kofoed, and B. Vester. 2000. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin. J. Mol. Biol. 304:471-481.
39. Prudhomme, M., L. Attaiech, G. Sanchez, B. Martin, and J. P. Claverys. 2006. Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae. Science 313:89-92.
40. Ross, J. I., et al. 1990. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol. 4:1207-1214.
41. Sandler, P., and B. Weisblum. 1989. Erythromycin-induced ribosome stall in the ermA leader: a barricade to 5′-to-3′ nucleolytic cleavage of the ermA transcript. J. Bacteriol. 171:6680-6688. (Pubitemid 20006951)
42. Schlunzen, F., et al. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413:814-821. (Pubitemid 33026843)
43. Stephens, D. S., et al. 2005. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 365:855-863. (Pubitemid 40332163)
44. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
45. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
46. Syrogiannopoulos, G. A., et al. 2003. Antimicrobial susceptibility and macrolide resistance inducibility of Streptococcus pneumoniae carrying erm(A), erm(B), or mef(A). Antimicrob. Agents Chemother. 47:2699-2702. (Pubitemid 36919486)
47. Tait-Kamradt, A., et al. 1997. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:2251-2255.
48. Weisblum, B. 1995. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob. Agents Chemother. 39:797-805.
49. Wierzbowski, A. K., D. Boyd, M. Mulvey, D. J. Hoban, and G. G. Zhanel. 2005. Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides. Antimicrob. Agents Chemother. 49:4635-4640.
50. Zähner, D., et al. 2010. Human antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 54:3516-3519.
51. Zhanel, G. G., and J. A. Karlowsky. 1999. Ribosomal resistance: emerging problems and potential solutions. Curr. Infect. Dis. Rep. 1:458-463.